Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Major Depressive Disorder, Bipolar I and Bipolar II”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Not applicableStudy completedNCT04358900
What this trial is testing

Unobtrusive Monitoring of Affective Symptoms and Cognition Using Keyboard Dynamics (UnMASCK)

Who this might be right for
Mood DisordersMajor Depressive DisorderBipolar Disorder I+3 more
University of Illinois at Chicago 132
Not applicableLooking for participantsNCT06804525
What this trial is testing

LHC-CIDI-5 in Hong Kong

Who this might be right for
Major Depressive Episode (MDE)Major Depressive Disorder (MDD)Persistent Depressive Disorder (PDD)+20 more
The University of Hong Kong 2,500
Not applicableStudy completedNCT00888264
What this trial is testing

A NIS Evaluating the Treatment Patterns of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder

Who this might be right for
Bipolar Disorders
AstraZeneca 152
Not applicableStudy completedNCT02330068
What this trial is testing

Microbiome of Depression & Treatment Response to Citalopram

Who this might be right for
Major Depressive Disorder, Bipolar I and Bipolar II
Mayo Clinic 34
Post-approval studies (Phase 4)Study completedNCT01430455
What this trial is testing

Tranylcypromine Treatment of Bipolar Depression

Who this might be right for
Bipolar Disorder I or II
New York State Psychiatric Institute 7
Large-scale testing (Phase 3)Looking for participantsNCT07412132
What this trial is testing

Evaluation of the Efficacy, Safety, and Tolerability of Lacosamide in Major Depressive Episodes of Bipolar Disorder Types I and II.

Who this might be right for
Bipolar Affective Disorder
University of Sao Paulo 40
Not applicableEnrolling By InvitationNCT00762866
What this trial is testing

Psychiatric Genotype/Phenotype Project Repository

Who this might be right for
Depressive Disorder, MajorBipolar DisorderPsychotic Disorders
Vanderbilt University 2,000
Large-scale testing (Phase 3)Looking for participantsNCT06372964
What this trial is testing

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

Who this might be right for
Bipolar Depression
Intra-Cellular Therapies, Inc. 384
Large-scale testing (Phase 3)Study completedNCT02600507
What this trial is testing

Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression

Who this might be right for
Bipolar Depression
Intra-Cellular Therapies, Inc. 529
Not applicableStudy completedNCT00006517
What this trial is testing

Clinical Trials of Three Non-Drug Treatments for Winter Depression (SAD)

Who this might be right for
Seasonal Affective DisorderMood DisordersDepression
New York State Psychiatric Institute 150
Large-scale testing (Phase 3)UnknownNCT03423680
What this trial is testing

Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression

Who this might be right for
Depression, Bipolar
Korea Otsuka Pharmaceutical Co., Ltd. 390
Testing effectiveness (Phase 2)Looking for participantsNCT07569198
What this trial is testing

Ketamine With Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder (KET-DBT)

Who this might be right for
Borderline Personality Disorder (BPD)Treatment-Resistant Major Depressive DisorderTreatment-resistant Bipolar Depression+4 more
Joshua Rosenblat 120
Testing effectiveness (Phase 2)Study completedNCT01731119
What this trial is testing

Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+10 more
University of North Carolina, Chapel Hill 9
Large-scale testing (Phase 3)Study completedNCT04285515
What this trial is testing

Clinical Trial Evaluating Lumateperone Monotherapy in the Treatment of Bipolar Depression or Major Depressive Disorder

Who this might be right for
Bipolar DepressionMajor Depressive Disorder
Intra-Cellular Therapies, Inc. 488
Large-scale testing (Phase 3)Study completedNCT00852592
What this trial is testing

Light Therapy for Bipolar Disorder. Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial

Who this might be right for
Bipolar DisorderMajor Depressive Episode
Northwestern University 46
Testing effectiveness (Phase 2)Study completedNCT03692910
What this trial is testing

Evaluate SAGE-217 in Participants With Bipolar I/II Disorder With a Current Major Depressive Episode

Who this might be right for
Bipolar Disorder IBipolar Disorder IIMajor Depressive Episode
Biogen 35
Large-scale testing (Phase 3)Study completedNCT01403662
What this trial is testing

Evaluating the Efficacy of Adjunctive Minocycline for the Treatment of Bipolar Depression

Who this might be right for
Bipolar DisorderBipolar DepressionBipolar I Depression+1 more
University Health Network, Toronto 29
Not applicableStudy completedNCT05870501
What this trial is testing

Synaptic Imaging and Network Activity in Treatment Resistant Depression

Who this might be right for
Depressive DisorderDepressive Disorder, MajorDepressive Disorder, Treatment-Resistant+5 more
King's College London 56
Not applicableStudy completedNCT02746367
What this trial is testing

Bipolar Proteomic Assay Validation Study

Who this might be right for
Major Depressive Disorder, Bipolar I and Bipolar II
Myriad Genetic Laboratories, Inc. 261
Large-scale testing (Phase 3)Study completedNCT03249376
What this trial is testing

Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally

Who this might be right for
Bipolar Depression
Intra-Cellular Therapies, Inc. 381
Next Page